Time to read: 2 minutes(s)

Whooping cough cases in Russia have broken a 30-year record.

In 2023, the infection was detected in almost 53 thousand people; the only time there were more was in 1993. 

At the same time, a number of clinics in several regions are experiencing shortages of one of the main vaccines, Pentaxim. пишет publication "Medvestnik".

Over the past year, the incidence rate has increased 15-fold. The increase has been recorded in all regions, including major cities and the capital. According to Rospotrebnadzor, 92% of all cases occurred in children under 17. 

Experts believe several factors are at play: routine childhood immunizations have dropped due to the COVID-19 pandemic, children are increasingly suffering from allergies and receiving medical exemptions, and the pertussis bacteria has become more aggressive, leading to more recurrent infections.

Meanwhile, some clinics and patients are complaining of shortages of the most commonly used vaccine, Pentaxim, said Antonina Oblasova, director of the organization "Collective Immunity." Regions experiencing supply problems include the Tomsk Region, St. Petersburg, and the Khanty-Mansi Autonomous Okrug. Regarding supply issues Reported Last year, the manufacturer was unable to ship it because it had not received a distribution plan for the drug from the Ministry of Health.  

The national immunization schedule provides coverage for whooping cough, tetanus, and diphtheria using either the domestically produced DPT vaccine or the imported Pentaxim vaccine (manufactured in Russia). Under the compulsory health insurance program, parents prefer to vaccinate their children with Pentaxim, as the domestically produced vaccine is considered more reactogenic.

Two more popular imported drugs that could be purchased with personal funds are now unavailable in Russia. 

Even if the vaccine shortage disappears, experts interviewed by the publication believe that a sharp decline in the incidence rate in 2024 is not worth expecting.